The Clinical Utility of Gene Expression Examination in Rheumatology

Overview

Journal Mediterr J Rheumatol

Specialty Rheumatology

Date 2020 Mar 19

PMID 32185269

Citations 1

Authors

Elena Tchetina

Galina Markova

Affiliations

Soon will be listed here.

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease with unknown etiology that affects various pathways within the immune system, involves many other tissues and is associated with pain and joint destruction. Current treatments fail to address pathophysiological and biochemical mechanisms involved in joint degeneration and the induction of pain. Moreover, RA patients are extremely heterogeneous and require specific treatments, the choice of which is complicated by the fact that not all patients equally respond to therapy. Gene expression analysis offer tools for patient management and personalization of patient's care to meet individual needs in controlling inflammation and pain and delaying joint destruction.

Citing Articles

Mediterranean Journal of Rheumatology September 2017 Highlights.

Sakkas L Mediterr J Rheumatol. 2020; 28(3):110-111.

PMID: 32185267 PMC: 7046060. DOI: 10.31138/mjr.28.3.110.

References

Tanino M, Matoba R, Nakamura S, Kameda H, Amano K, Okayama T . Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells. Biochem Biophys Res Commun. 2009; 387(2):261-5. DOI: 10.1016/j.bbrc.2009.06.149. View

Kim T, Choi S, Lee Y, Song G, Ji J . Gene expression profile predicting the response to anti-TNF treatment in patients with rheumatoid arthritis; analysis of GEO datasets. Joint Bone Spine. 2014; 81(4):325-30. DOI: 10.1016/j.jbspin.2014.01.013. View

Green M, Gough A, Devlin J, Smith J, Astin P, Taylor D . Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford). 2003; 42(1):83-8. DOI: 10.1093/rheumatology/keg037. View

Brown A, Conaghan P, Karim Z, Quinn M, Ikeda K, Peterfy C . An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008; 58(10):2958-67. DOI: 10.1002/art.23945. View

Hao L, Zhu G, Lu Y, Wang M, Jules J, Zhou X . Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role. FEBS Lett. 2015; 589(12):1331-1339. PMC: 4623593. DOI: 10.1016/j.febslet.2015.04.008. View

Chen Y, Chen H, Lan J, Chen D . Improvement of cognition, a potential benefit of anti-TNF therapy in elderly patients with rheumatoid arthritis. Joint Bone Spine. 2010; 77(4):366-7. DOI: 10.1016/j.jbspin.2010.01.017. View

Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Schett G . Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann Rheum Dis. 2012; 72(3):396-400. DOI: 10.1136/annrheumdis-2011-201075. View

Tarp S, Furst D, Boers M, Luta G, Bliddal H, Tarp U . Risk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta-analysis. Rheumatology (Oxford). 2016; 56(3):417-425. DOI: 10.1093/rheumatology/kew442. View

Malfait A, Schnitzer T . Towards a mechanism-based approach to pain management in osteoarthritis. Nat Rev Rheumatol. 2013; 9(11):654-64. PMC: 4151882. DOI: 10.1038/nrrheum.2013.138. View

10.

Yunus M . The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat. 2011; 2012:584573. PMC: 3236313. DOI: 10.1155/2012/584573. View

11.

Tchetina E, Demidova N, Karateev D, Nasonov E . Rheumatoid factor positivity is associated with increased joint destruction and upregulation of matrix metalloproteinase 9 and cathepsin k gene expression in the peripheral blood in rheumatoid arthritic patients treated with methotrexate. Int J Rheumatol. 2013; 2013:457876. PMC: 3848347. DOI: 10.1155/2013/457876. View

12.

Tveita A, Rekvig O, Zykova S . Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis. Arthritis Res Ther. 2008; 10(6):229. PMC: 2656222. DOI: 10.1186/ar2532. View

13.

Lisowska B, Maslinski W, Maldyk P, Zabek J, Baranowska E . The role of cytokines in inflammatory response after total knee arthroplasty in patients with rheumatoid arthritis. Rheumatol Int. 2007; 28(7):667-71. DOI: 10.1007/s00296-007-0508-1. View

14.

Peng W, Yan J, Wan Y, Wang B, Tao J, Yang G . Matrix metalloproteinases: a review of their structure and role in systemic sclerosis. J Clin Immunol. 2012; 32(6):1409-14. DOI: 10.1007/s10875-012-9735-7. View

15.

Seyler T, Park Y, Takemura S, Bram R, Kurtin P, Goronzy J . BLyS and APRIL in rheumatoid arthritis. J Clin Invest. 2005; 115(11):3083-92. PMC: 1257539. DOI: 10.1172/JCI25265. View

16.

Latremoliere A, Woolf C . Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10(9):895-926. PMC: 2750819. DOI: 10.1016/j.jpain.2009.06.012. View

17.

ORourke K, ODonoghue G, Adams C, Mulcahy H, Molloy C, Silke C . High levels of Lymphotoxin-Beta (LT-Beta) gene expression in rheumatoid arthritis synovium: clinical and cytokine correlations. Rheumatol Int. 2008; 28(10):979-86. DOI: 10.1007/s00296-008-0574-z. View

18.

Reichling D, Green P, Levine J . The fundamental unit of pain is the cell. Pain. 2013; 154 Suppl 1:S2-9. PMC: 3858489. DOI: 10.1016/j.pain.2013.05.037. View

19.

Gossec L, Paternotte S, Aanerud G, Balanescu A, Boumpas D, Carmona L . Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis. 2011; 70(6):935-42. DOI: 10.1136/ard.2010.142901. View

20.

Ren K, Dubner R . Interactions between the immune and nervous systems in pain. Nat Med. 2010; 16(11):1267-76. PMC: 3077564. DOI: 10.1038/nm.2234. View